LIQUIDIA CORPORATION Total Assets
LIQUIDIA CORPORATION (LQDA) had Total Assets of $521.92 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-12
- 2026-06-30: Assets $521.92M.
- 2026-03-31: Assets $401.53M.
- 2025-12-31: Assets $327.93M.
- 2025-09-30: Assets $275.98M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $521.92M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $401.53M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $327.93M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $275.98M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $257.41M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $227.43M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $230.31M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $252.89M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $177.36M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $197.12M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $118.33M 8-K · filed 2025-05-08 | |
| 2023-09-30 | $111.64M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $121.60M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $128.92M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $129.20M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $132.57M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $139.08M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $93.53M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $93.73M 10-K · filed 2023-03-20 | $93.73M 10-K · filed 2022-03-17 |
| 2021-09-30 | $100.30M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $104.38M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $88.45M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $99.53M 10-K · filed 2022-03-17 | |
| 2019-12-31 | $68.84M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |